The weekly litigation news digest is live. Subscribe now
Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry Disease - EP3914247
The patent EP3914247 was granted to Amicus Therapeutics on Nov 13, 2024. The application was originally filed on Jan 22, 2020 under application number EP20708283A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP3914247
- Application Number
- EP20708283A
- Filing Date
- Jan 22, 2020
- Status
- Granted And Under Opposition
- Oct 11, 2024
- Publication Date
- Nov 13, 2024
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Patent Oppositions (3)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (8) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents